2013
DOI: 10.1016/j.parkreldis.2012.09.014
|View full text |Cite
|
Sign up to set email alerts
|

Epidemiology and neuropsychiatric manifestations of Young Onset Parkinson's Disease in the United States

Abstract: Background To determine the demographic distribution of Young Onset Parkinson’s Disease (YOPD) in the United States and to quantify the burden of neuropsychiatric disease manifestations. Methods Cross sectional study of 3,459,986 disabled Americans, aged 30 to 54, who were receiving Medicare benefits in the year 2005. We calculated race and sex distributions of YOPD and used logistic regression to compare the likelihood of common and uncommon psychiatric disorders between beneficiaries with YOPD and the gene… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
16
0
1

Year Published

2014
2014
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 43 publications
(18 citation statements)
references
References 24 publications
(30 reference statements)
1
16
0
1
Order By: Relevance
“…17 BED, also referred to in the literature as pathological overeating, occurs in approximately 2% of the general U.S. population. 18 The few studies done to date suggest that ICDs may be more common, overall, in treated PD patients, compared to healthy controls (HCs), 19,20 or similarly disabled non-PD patients, 21,22 although one recent study suggested otherwise. 23 Determining the frequency of impulse control symptoms in de novo, untreated PD patients would help answer the question of whether PD itself confers an increased (or indeed decreased) risk for experiencing such symptoms.…”
Section: Frequencymentioning
confidence: 99%
“…17 BED, also referred to in the literature as pathological overeating, occurs in approximately 2% of the general U.S. population. 18 The few studies done to date suggest that ICDs may be more common, overall, in treated PD patients, compared to healthy controls (HCs), 19,20 or similarly disabled non-PD patients, 21,22 although one recent study suggested otherwise. 23 Determining the frequency of impulse control symptoms in de novo, untreated PD patients would help answer the question of whether PD itself confers an increased (or indeed decreased) risk for experiencing such symptoms.…”
Section: Frequencymentioning
confidence: 99%
“…A subset of models were adjusted for presence or absence of tobacco use in the patient data (ICD-9-CM codes 305.1, tobacco use disorders; 989.84, toxic effect of tobacco; and V15.82, history tobacco use history). In addition to gender, PD prevalence differs between racial and ethnic groups (Willis et al, 2013). Most individuals living in Utah are whites of non-Hispanic ethnicity (80%), with the largest minority population comprised of Hispanic or Latino individuals of any race (13%; Utah Governor’s Office of Planning and Budget, 2012).…”
Section: Methodsmentioning
confidence: 99%
“…In addition, young-onset PD patients, who are more likely to develop ICBs, are significantly more likely to have co-morbid depression, substance abuse/dependence, personality/impulse control disorders, and psychosocial dysfunction relative to 3.5 million disabled Americans, aged 30–54 adjusting for race, age, and sex (Willis, Schootman et al 2013). Some authors have suggested that the development of ICBs may reflect a coping mechanism following a diagnosis of PD (Delaney, Leroi et al 2012).…”
Section: Risk Factors For Icbs In Pdmentioning
confidence: 99%